ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation.

PubWeight™: 1.79‹?› | Rank: Top 3%

🔗 View Article (PMC 2766867)

Published in Cancer Biol Ther on June 25, 2009

Authors

Xuguang Zheng1, Feng Jiang, Mark Katakowski, Zheng Gang Zhang, Qing-e Lu, Michael Chopp

Author Affiliations

1: Department of Neurology, Henry Ford Hospital, Detroit, MI 48202, USA.

Articles citing this

ADAM-17: the enzyme that does it all. Crit Rev Biochem Mol Biol (2010) 1.62

The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer? Clin Proteomics (2011) 1.50

Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer. OMICS (2011) 1.23

ADAM17 promotes glioma cell malignant phenotype. Mol Carcinog (2011) 1.08

MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells. Oncol Rep (2012) 0.96

Anti-tumour effects of a specific anti-ADAM17 antibody in an ovarian cancer model in vivo. PLoS One (2012) 0.95

Gallic acid reduces cell viability, proliferation, invasion and angiogenesis in human cervical cancer cells. Oncol Lett (2013) 0.93

p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cells. J Biol Chem (2014) 0.91

ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling. PLoS One (2012) 0.89

Tumorigenicity of cortical astrocyte cell line induced by the protease ADAM17. Cancer Sci (2009) 0.86

Transcription factor Sp1 induces ADAM17 and contributes to tumor cell invasiveness under hypoxia. J Exp Clin Cancer Res (2009) 0.85

ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC. Cancer Med (2013) 0.84

Histone H1 phosphorylation in breast cancer. J Proteome Res (2014) 0.83

Targeting the sheddase activity of ADAM17 by an anti-ADAM17 antibody D1(A12) inhibits head and neck squamous cell carcinoma cell proliferation and motility via blockage of bradykinin induced HERs transactivation. Int J Biol Sci (2014) 0.81

Dual-color fluorescence imaging in a nude mouse orthotopic glioma model. J Neurosci Methods (2009) 0.80

ADAM17: the new face of breast cancer-promoting metalloprotease activity. Cancer Biol Ther (2009) 0.79

Inhibition of breast cancer growth and metastasis by a biomimetic peptide. Sci Rep (2014) 0.79

Heparin-binding epidermal growth factor-like growth factor is a potent regulator of invasion activity in oral squamous cell carcinoma. Oncol Rep (2011) 0.78

The effects of amphiregulin induced MMP-13 production in human osteoarthritis synovial fibroblast. Mediators Inflamm (2014) 0.77

Overexpression of miR‑145 in U87 cells reduces glioma cell malignant phenotype and promotes survival after in vivo implantation. Int J Oncol (2014) 0.77

Articles cited by this

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (1984) 17.70

Cellular survival: a play in three Akts. Genes Dev (1999) 17.05

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature (1997) 10.14

Angiogenesis. Annu Rev Med (2006) 6.94

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature (1997) 6.06

ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol (2005) 5.97

The EGF receptor family as targets for cancer therapy. Oncogene (2000) 5.44

Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol (2004) 5.44

EGF receptor. Int J Biochem Cell Biol (1999) 3.91

Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem (1998) 3.83

EGF receptor ligands. Exp Cell Res (2003) 3.60

Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci U S A (2000) 3.40

The ADAMs: signalling scissors in the tumour microenvironment. Nat Rev Cancer (2008) 2.90

The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet (2000) 2.64

Targeting TACE-dependent EGFR ligand shedding in breast cancer. J Clin Invest (2007) 2.29

ADAMs family members as amyloid precursor protein alpha-secretases. J Neurosci Res (2003) 2.29

Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion. Cancer Res (2002) 2.23

PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta (2007) 1.88

Tumor necrosis factor-alpha converting enzyme. Int J Biochem Cell Biol (2002) 1.83

A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J Exp Med (1995) 1.76

A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J Immunol (1995) 1.70

Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1alpha, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling. J Biol Chem (2004) 1.45

Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness. Cancer Sci (2007) 1.35

TACE: a new target in epidermal growth factor receptor dependent tumors. Differentiation (2007) 1.18

Ectodomain shedding of the hypoxia-induced carbonic anhydrase IX is a metalloprotease-dependent process regulated by TACE/ADAM17. Br J Cancer (2005) 1.12

UVA-induced cell cycle progression is mediated by a disintegrin and metalloprotease/epidermal growth factor receptor/AKT/Cyclin D1 pathways in keratinocytes. Cancer Res (2008) 1.12

Regulation of angiogenesis and tumor growth by p110 alpha and AKT1 via VEGF expression. J Cell Physiol (2006) 1.10

ADAM17 mRNA expression and pathological features of hepatocellular carcinoma. World J Gastroenterol (2004) 1.10

The ADAM17-amphiregulin-EGFR axis in mammary development and cancer. J Mammary Gland Biol Neoplasia (2008) 1.06

Hydroxamate-based metalloprotease inhibitor blocks shedding of L-selectin adhesion molecule from leukocytes: functional consequences for neutrophil aggregation. J Immunol (1996) 1.06

ADAM-17 predicts adverse outcome in patients with breast cancer. Ann Oncol (2008) 1.04

Sensitization of cerebral tissue in nude mice with photodynamic therapy induces ADAM17/TACE and promotes glioma cell invasion. Cancer Lett (2008) 1.01

[Glioblastomas: clinical study and search for prognostic factors]. Neurochirurgie (2002) 0.96

Stroke-induced subventricular zone proliferation is promoted by tumor necrosis factor-alpha-converting enzyme protease activity. J Cereb Blood Flow Metab (2006) 0.95

Three-dimensional extracellular matrix culture models of EGFR signalling and drug response. Biochem Soc Trans (2007) 0.91

Articles by these authors

Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res (2003) 4.29

JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16. Proc Natl Acad Sci U S A (2005) 3.68

Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol (2003) 3.54

Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke (2004) 3.53

Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol (2009) 3.27

Animal models of traumatic brain injury. Nat Rev Neurosci (2013) 2.75

Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia (2005) 2.68

Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J Cereb Blood Flow Metab (2005) 2.65

Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res (2003) 2.61

Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res (2002) 2.45

Activated neural stem cells contribute to stroke-induced neurogenesis and neuroblast migration toward the infarct boundary in adult rats. J Cereb Blood Flow Metab (2004) 2.41

Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology (2002) 2.38

Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest (2010) 2.37

A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J Neurosci Methods (2002) 2.35

ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome. Lab Invest (2009) 2.25

Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke (2002) 2.24

Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab (2002) 2.22

Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Nat Med (2006) 2.22

Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke. Stroke (2007) 2.22

Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer (2010) 2.20

De novo analysis of transcriptome dynamics in the migratory locust during the development of phase traits. PLoS One (2010) 2.19

Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst (2002) 2.16

Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery (2003) 2.16

Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells (2012) 2.14

Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer (2009) 2.14

Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol (2005) 2.11

Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab (2006) 2.10

Stromal cell-derived factor 1alpha mediates neural progenitor cell motility after focal cerebral ischemia. J Cereb Blood Flow Metab (2006) 2.06

Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. J Neurosci (2006) 2.06

C3PO, an endoribonuclease that promotes RNAi by facilitating RISC activation. Science (2009) 2.04

Improvement in functional recovery with administration of Cerebrolysin after experimental closed head injury. J Neurosurg (2013) 2.02

Dicer-2 and R2D2 coordinately bind siRNA to promote assembly of the siRISC complexes. RNA (2006) 1.98

Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J Cereb Blood Flow Metab (2007) 1.89

Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J Neurotrauma (2004) 1.87

Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Cancer Epidemiol Biomarkers Prev (2010) 1.85

Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab (2013) 1.85

Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. J Neurosci Res (2002) 1.85

Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat. Circ Res (2003) 1.81

Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod Pathol (2010) 1.80

Induction of hepatitis by JNK-mediated expression of TNF-alpha. Cell (2009) 1.79

Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke. Circulation (2003) 1.77

Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury. J Neurotrauma (2007) 1.76

Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer (2011) 1.74

Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J Neurotrauma (2005) 1.74

MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett (2012) 1.73

Low-level laser therapy applied transcranially to rats after induction of stroke significantly reduces long-term neurological deficits. Stroke (2006) 1.72

MRI detects white matter reorganization after neural progenitor cell treatment of stroke. Neuroimage (2006) 1.69

Marrow stromal cell transplantation after traumatic brain injury promotes cellular proliferation within the brain. Neurosurgery (2004) 1.68

Angiogenesis, neurogenesis and brain recovery of function following injury. Curr Opin Investig Drugs (2010) 1.67

Suppression of p53-dependent senescence by the JNK signal transduction pathway. Proc Natl Acad Sci U S A (2007) 1.67

The neurovascular unit and combination treatment strategies for stroke. Trends Pharmacol Sci (2012) 1.66

Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. J Cereb Blood Flow Metab (2007) 1.64

Functional microRNA is transferred between glioma cells. Cancer Res (2010) 1.63

Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury. J Neurotrauma (2008) 1.62

Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer. Cancer Res (2003) 1.61

Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol (2012) 1.60

MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology (2002) 1.59

Marrow stromal cell transplantation in stroke and traumatic brain injury. Neurosci Lett (2009) 1.58

Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II. Stroke (2011) 1.58

Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat. Wound Repair Regen (2006) 1.58

Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. Clin Cancer Res (2007) 1.57

Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant (2002) 1.57

One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke. Stroke (2007) 1.57

Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Mol Cancer (2010) 1.56

Stroke transiently increases subventricular zone cell division from asymmetric to symmetric and increases neuronal differentiation in the adult rat. J Neurosci (2004) 1.55

Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J Neurosci (2005) 1.54

MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells (2013) 1.51

Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett (2013) 1.51

Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target. Cancer Res (2007) 1.51

Contralesional axonal remodeling of the corticospinal system in adult rats after stroke and bone marrow stromal cell treatment. Stroke (2008) 1.49

Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury. J Neurotrauma (2004) 1.49

MicroRNA-21 protects neurons from ischemic death. FEBS J (2010) 1.48

Functional recovery in aged and young rats after embolic stroke: treatment with a phosphodiesterase type 5 inhibitor. Stroke (2005) 1.46

Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. J Cereb Blood Flow Metab (2009) 1.43

Investigation of neural progenitor cell induced angiogenesis after embolic stroke in rat using MRI. Neuroimage (2005) 1.41

Neuroblast division during migration toward the ischemic striatum: a study of dynamic migratory and proliferative characteristics of neuroblasts from the subventricular zone. J Neurosci (2007) 1.41